Chemoinformaics analysis of Trans-Cinnamic acid
Molecular Weight | 148.161 | nRot | 2 |
Heavy Atom Molecular Weight | 140.097 | nRig | 8 |
Exact Molecular Weight | 148.052 | nRing | 1 |
Solubility: LogS | -2.051 | nHRing | 0 |
Solubility: LogP | 2.363 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 21.9683 |
nHD | 1 | BPOL | 8.89366 |
QED | 0.649 |
Synth | 1.535 |
Natural Product Likeliness | 0.404 |
NR-PPAR-gamma | 0.021 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.028 |
HIA | 0.013 |
CACO-2 | -4.797 |
MDCK | 0.0000191 |
BBB | 0.614 |
PPB | 0.887172 |
VDSS | 0.221 |
FU | 0.0590179 |
CYP1A2-inh | 0.097 |
CYP1A2-sub | 0.078 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.061 |
CYP2c9-inh | 0.237 |
CYP2c9-sub | 0.35 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.128 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.127 |
CL | 2.221 |
T12 | 0.892 |
hERG | 0.024 |
Ames | 0.07 |
ROA | 0.14 |
SkinSen | 0.951 |
Carcinogencity | 0.047 |
EI | 0.992 |
Respiratory | 0.624 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.860723 |